Medical artificial intelligence (AI) startup Beamworks (CEO Kim Won-hwa and Kim Jae-il) will provide real-time AI diagnosis of breast ultrasound at the ’80th Korean Society of Radiology (KCR 2024)’ held at COEX, Seoul from today (2nd) to 5th. They announced that they will announce two latest research results using the auxiliary solution ‘CadAI-B’.
‘CadAI-B’ is an AI solution that detects cancer in real time from breast ultrasound images and assists breast cancer differential diagnosis, and is a level 3 medical device software designated as the 23rd innovative medical device.
At this conference, Professor Jeonghyeon Yoon of Yonsei University College of Medicine will present the results of a study evaluating the clinical effectiveness of ‘CadAI-B’ as a real-time ultrasound cancer diagnosis assistant AI. This study is a large-scale confirmatory clinical study involving 1,000 cases of data and 15 diverse users who provide ultrasound diagnosis, including radiology, family medicine, obstetrics and gynecology, and breast surgery.
According to the research results, when comparing before and after using ‘CadAI-B’, the consistency and accuracy of diagnosis significantly increased (AUC 0.89 before use, 0.94 after use), especially when unskilled people received help from AI. Results showed that cancer could be detected and diagnosed more accurately. In recognition of the value of the research in the field of ultrasound cancer diagnosis, the research was awarded the KCR Best Abstract Award.
Professor Yoon said, “This study evaluated the clinical usefulness of ‘CadAI-B’ and demonstrated that breast ultrasound diagnostic performance was significantly improved when used by examiners from various professional occupations in an actual clinical environment.” He added, “The results of this study indicate that examiners from various professions who perform breast ultrasound examinations using ‘CadAI-B’ can more effectively diagnose breast cancer, and in particular, it shows the potential to be used effectively in breast ultrasound examinations.” .
In addition, the Beamworks research team plans to introduce the results of a prospective clinical study conducted using ‘CadAI-B’ on breast cancer patients at a Taiwanese medical institution from August to December 2023 at KCR 2024. In this study using ultrasound images collected from 33 patients, ‘CadAI-B’ showed similar performance in distinguishing benign from malignant compared to experts, thereby eliminating unnecessary invasive diagnosis of breast cancer that leads to biopsy. It showed the possibility of shortening the process.
Kim Won-hwa, CEO of Beamworks Kim Jae-il, said, “The research results presented at this KCR 2024 are important examples that prove the clinical value of ‘CadAI-B’ in the field of radiology,” adding, “We will improve the accuracy and efficiency of ultrasound cancer diagnosis through AI technology.” “We will continue to strive to increase it even further,” he said.
Meanwhile, KCR 2024 is a global academic conference hosted by the Korean Society of Radiology, and more than 3,800 radiology officials from about 41 countries are expected to attend.
Choi Yong-seok, Donga.com reporter [email protected]
-
- great
- 0dog
-
- I’m sad
- 0dog
-
- I’m angry
- 0dog
-
- I recommend it
- dog
Hot news now
2024-10-02 07:46:44